| Disease |
Strain |
Study |
References |
| Hypercholesterolemia |
Enterococcus faecium;Lactobacillus
plantarum PH04 |
Randomized into two groups, oral application;For 14 days, the mice were fed a high-cholesterol diet.Subsequent 14 days, doses of probiotic were orallyadministered to half the mice/feed of mice |
[123]
[124] |
| Traveller’s diarrhea |
Lactobacillus casei
DN-114 001, L.plantarum |
Patients were randomlyassigned to a probiotic drink or placebo, in a double-blindfashion |
[125] |
| Gastroenteritis |
Lactobacillus casei |
For the elderly was introducedprobiotic fermented milkcontaining Lactobacillus caseistrain Shirota (LcS-fermented milk) in an open case-controlstudy of its effect of (1 bottle aday) on winter-time norovirusgastroenteritis |
[126] |
| Irritable bowel syndrome (IBS) |
Bifidobacterium
infantis 35624 |
362 primary care IBS patients,with any bowel habit subtype, were randomized to either placebo or freeze-dried,encapsulated B. infantis |
[127] |
| Urogenital tract infection (UTI) |
Lactobacillus
rhamnosus GR-1
L. reuteri RC-14 |
Was assessed in a pilot two-patientstudy in which probiotic were administered to one patient and placebo toanother, both along with antibiotics |
[128] |
| Eczema |
Bifidobacteriumbifidum
B. lactis
Lactococcus lactis |
In a double-blind, randomized,placebo-controlled trial, a mixture of probiotic bacteria selected by in-vitroexperiments was prenatallyadministered to mothers of high-risk children and to their offspring for the first 12months of life |
[129] |
| Immunity |
Lactobacillusplantarum DSMZ12028 |
In vitro study, adhesion to intestinal epithelial cells wasevaluated using two cell lines,CaCo-2 and HT-29, throughthe plate dilution method |
[23] |
